|
| 34496035 | BCR-ABL1 transcript doubling time as a predictor for treatment-free remission failure after imatinib discontinuation in chronic myeloid leukaemia in chronic phase. | Br J Haematol | 2022 |
| 31896684 | Measurable residual disease monitoring provides insufficient lead-time to prevent morphologic relapse in the majority of patients with core-binding factor acute myeloid leukemia. | Haematologica | 2021 |
| 33876423 | Optimal duration of imatinib treatment/deep molecular response for treatment-free remission after imatinib discontinuation from a Canadian tyrosine kinase inhibitor discontinuation trial. | Br J Haematol | 2021 |
| 33858678 | The Prevent Ovarian Cancer Program (POCP): Identification of women at risk for ovarian cancer using complementary recruitment approaches. | Gynecol Oncol | 2021 |
| 35112092 | Effects of Ethnicity on Outcomes of Patients With <i>EGFR</i> Mutation-Positive NSCLC Treated With EGFR Tyrosine Kinase Inhibitors and Surgical Resection. | JTO Clin Res Rep | 2021 |
| 31274700 | HPV-independent Vulvar Squamous Cell Carcinoma is Associated With Significantly Worse Prognosis Compared With HPV-associated Tumors. | Int J Gynecol Pathol | 2020 |
| 35050743 | Multicenter Validation Study to Implement Plasma Epidermal Growth Factor Receptor T790M Testing in Clinical Laboratories. | JCO Precis Oncol | 2020 |
| 31846781 | The predictive value of intracellular imatinib levels in newly diagnosed chronic myeloid leukemia. | Leuk Res | 2020 |
| 31992589 | Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86). | Clin Cancer Res | 2020 |
| 31953485 | Latency and interval therapy affect the evolution in metastatic colorectal cancer. | Sci Rep | 2020 |
| 32015424 | A 4-gene signature from histologically normal surgical margins predicts local recurrence in patients with oral carcinoma: clinical validation. | Sci Rep | 2020 |
| 30387329 | Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation. | J Pathol Clin Res | 2019 |
| 31896933 | The Somatic Curation and Interpretation Across Laboratories (SOCIAL) project-current state of solid-tumour variant interpretation for molecular pathology in Canada. | Curr Oncol | 2019 |
| 31708655 | OCTANE (Ontario-wide Cancer Targeted Nucleic Acid Evaluation): a platform for intraprovincial, national, and international clinical data-sharing. | Curr Oncol | 2019 |
| 30170099 | Genomic Classifier for Guiding Treatment of Intermediate-Risk Prostate Cancers to Dose-Escalated Image Guided Radiation Therapy Without Hormone Therapy. | Int J Radiat Oncol Biol Phys | 2019 |
| 31371380 | Impact of preleukemic mutations and their persistence on hematologic recovery after induction chemotherapy for AML. | Blood Adv | 2019 |
| 30770327 | Effect of Coexisting KRAS and TP53 Mutations in Patients Treated With Chemotherapy for Non-small-cell Lung Cancer. | Clin Lung Cancer | 2019 |
| 30969158 | Performance Comparison of Different Analytic Methods in Proficiency Testing for Mutations in the <i>BRAF</i>, <i>EGFR</i>, and <i>KRAS</i> Genes: A Study of the College of American Pathologists Molecular Oncology Committee. | Arch Pathol Lab Med | 2019 |
| 30792002 | Impact of somatic molecular profiling on clinical trial outcomes in rare epithelial gynecologic cancer patients. | Gynecol Oncol | 2019 |
| 30376374 | Proficiency Testing of Standardized Samples Shows Very High Interlaboratory Agreement for Clinical Next-Generation Sequencing-Based Oncology Assays. | Arch Pathol Lab Med | 2019 |
| 30576869 | Somatic Tumor Variant Filtration Strategies to Optimize Tumor-Only Molecular Profiling Using Targeted Next-Generation Sequencing Panels. | J Mol Diagn | 2019 |
| 28891048 | Identifying actionable variants using next generation sequencing in patients with a historical diagnosis of undifferentiated pleomorphic sarcoma. | Int J Cancer | 2018 |
| 35135130 | Minimally Invasive Real-Time Detection of Actionable Mutations in Patients With Metastatic Solid Tumors Using Fine-Needle and Liquid Biopsies. | JCO Precis Oncol | 2018 |
| 31723772 | Clinical Utility of Next-generation Sequencing in the Management of Myeloproliferative Neoplasms: A Single-Center Experience. | Hemasphere | 2018 |
| 29854298 | Lung cancer in never smokers from the Princess Margaret Cancer Centre. | Oncotarget | 2018 |
| 30092803 | Additional germline findings from a tumor profiling program. | BMC Med Genomics | 2018 |
| 30249785 | Distinct patterns of clonal evolution in patients with concurrent myelo- and lymphoproliferative neoplasms. | Blood | 2018 |
| 30089591 | The prognostic effect of single and multiple cancer-related somatic mutations in resected non-small-cell lung cancer. | Lung Cancer | 2018 |
| 30327374 | The mutational landscape of accelerated- and blast-phase myeloproliferative neoplasms impacts patient outcomes. | Blood Adv | 2018 |
| 29449057 | Prognostic Significance of Human Papilloma Virus and p16 Expression in Patients with Vulvar Squamous Cell Carcinoma who Received Radiotherapy. | Clin Oncol (R Coll Radiol) | 2018 |
| 29719432 | Evidence-based best practices for <i>EGFR</i> T790M testing in lung cancer in Canada. | Curr Oncol | 2018 |
| 29518628 | AML refractory to primary induction with Ida-FLAG has a poor clinical outcome. | Leuk Res | 2018 |
| 29535011 | Translation of Knowledge to Practice-Improving Awareness in NSCLC Molecular Testing. | J Thorac Oncol | 2018 |
| 29507487 | Standardizing biomarker testing for Canadian patients with advanced lung cancer. | Curr Oncol | 2018 |
| 29128266 | Molecular Profiling of Patients With Advanced Colorectal Cancer: Princess Margaret Cancer Centre Experience. | Clin Colorectal Cancer | 2018 |
| 29055897 | T cell clonality assessment: past, present and future. | J Clin Pathol | 2018 |
| 29177603 | Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer. | Breast Cancer Res Treat | 2018 |
| 29145543 | Association of Ipilimumab With Safety and Antitumor Activity in Women With Metastatic or Recurrent Human Papillomavirus-Related Cervical Carcinoma. | JAMA Oncol | 2018 |
| 29242895 | Comparison of Laboratory-Developed Tests and FDA-Approved Assays for BRAF, EGFR, and KRAS Testing. | JAMA Oncol | 2018 |
| 28747393 | Improving validation methods for molecular diagnostics: application of Bland-Altman, Deming and simple linear regression analyses in assay comparison and evaluation for next-generation sequencing. | J Clin Pathol | 2018 |
| 28062115 | Genotype-matched treatment for patients with advanced type I epithelial ovarian cancer (EOC). | Gynecol Oncol | 2017 |
| 28363487 | Treatment options for patients with brain metastases from EGFR/ALK-driven lung cancer. | Radiother Oncol | 2017 |
| 28217853 | Use of cytological samples of metastatic melanoma for ancillary studies. | Cytopathology | 2017 |
| 28475299 | Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens. | Cancer Cytopathol | 2017 |
| 28492226 | Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates. | Nat Commun | 2017 |
| 28341590 | Guidelines for Validation of Next-Generation Sequencing-Based Oncology Panels: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists. | J Mol Diagn | 2017 |
| 28490925 | Management of <i>EGFR-</i>mutated non-small-cell lung cancer: practical implications from a clinical and pathology perspective. | Curr Oncol | 2017 |
| 28490924 | Improving molecular testing and personalized medicine in non-small-cell lung cancer in Ontario. | Curr Oncol | 2017 |
| 29028368 | A Window Into Clinical Next-Generation Sequencing-Based Oncology Testing Practices. | Arch Pathol Lab Med | 2017 |
| 29248130 | Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients. | Semin Oncol | 2017 |